FDA approves expanded emergency use of remdesivir in moderate COVID-19 patients
The drug can now be used to treat all hospitalized patients with COVID-19, in addition to patients with a severe form of the illness.
Full Article
FDA approves expanded emergency use of remdesivir in moderate COVID-19 patients
Hindu
0 shares
1 views
You might like
Related news coverage
FDA Will Consider OK'ing COVID-19 Vaccine Before End Of Phase 3 Trials
Newsy
Watch VideoThe head of the Food and Drug Administration says he’d consider bypassing the usual approval process to get a..
-
NA Proactive news snapshot: Aequus Pharmaceuticals, Acasti Pharma, Internet of Things, Revive Therapeutics UPDATE ....
Proactive Investors
-
Revive Therapeutics wins Institutional Review Board approval for its Phase 3 trial protocol to evaluate Bucillamine in COVID-19 patients
Proactive Investors
-
U.S. FDA chief willing to approve a COVID-19 vaccine before Phase 3 trials end
National Post
-
'Without evidence': Once again, FDA expands use of COVID-19 treatment without research to back it up
USATODAY.com
Advertisement
More coverage
FDA approves expanded use of remdesivir in moderate COVID-19 patients
Jerusalem Post
The drug was authorized in May for use in patients with a severe form of the illness, after trial data showed the antiviral drug..
-
Gilead Gains Expanded FDA Authorization for COVID-19 Treatment Remdesivir
Motley Fool
-
FDA OKs emergency use of Gilead's remdesivir for moderate COVID-19
SeekingAlpha
-
Abbott stock rising as FDA greenlights 15-minute COVID-19 test
Proactive Investors
-
NA Proactive news snapshot: Cardiol Therapeutics, Gold Resource Corporation, HighGold Mining, Revive Therapeutics, Newgioco Group, KULR Technology UPDATE …
Proactive Investors